These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10707958)

  • 1. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB.
    Jurutka PW; Remus LS; Whitfield GK; Thompson PD; Hsieh JC; Zitzer H; Tavakkoli P; Galligan MA; Dang HT; Haussler CA; Haussler MR
    Mol Endocrinol; 2000 Mar; 14(3):401-20. PubMed ID: 10707958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription.
    Masuyama H; Jefcoat SC; MacDonald PN
    Mol Endocrinol; 1997 Feb; 11(2):218-28. PubMed ID: 9013769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the 1,25-dihydroxyvitamin D3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding, and interaction with basal transcription factor IIB, in vitro.
    Jurutka PW; Hsieh JC; Remus LS; Whitfield GK; Thompson PD; Haussler CA; Blanco JC; Ozato K; Haussler MR
    J Biol Chem; 1997 Jun; 272(23):14592-9. PubMed ID: 9169418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
    Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
    Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation and dimerization functions in the human vitamin D receptor.
    Jin CH; Kerner SA; Hong MH; Pike JW
    Mol Endocrinol; 1996 Aug; 10(8):945-57. PubMed ID: 8843411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptor.
    Hsieh JC; Whitfield GK; Oza AK; Dang HT; Price JN; Galligan MA; Jurutka PW; Thompson PD; Haussler CA; Haussler MR
    Biochemistry; 1999 Dec; 38(49):16347-58. PubMed ID: 10587460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel nuclear localization signal between the two DNA-binding zinc fingers in the human vitamin D receptor.
    Hsieh JC; Shimizu Y; Minoshima S; Shimizu N; Haussler CA; Jurutka PW; Haussler MR
    J Cell Biochem; 1998 Jul; 70(1):94-109. PubMed ID: 9632111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation.
    Whitfield GK; Hsieh JC; Nakajima S; MacDonald PN; Thompson PD; Jurutka PW; Haussler CA; Haussler MR
    Mol Endocrinol; 1995 Sep; 9(9):1166-79. PubMed ID: 7491109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants.
    Gross C; Krishnan AV; Malloy PJ; Eccleshall TR; Zhao XY; Feldman D
    J Bone Miner Res; 1998 Nov; 13(11):1691-9. PubMed ID: 9797477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element.
    Nakajima S; Hsieh JC; MacDonald PN; Galligan MA; Haussler CA; Whitfield GK; Haussler MR
    Mol Endocrinol; 1994 Feb; 8(2):159-72. PubMed ID: 8170472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the activation function-2 domain of the human 1,25-dihydroxyvitamin D3 receptor.
    Nakajima S; Yamagata M; Sakai N; Ozono K
    Mol Cell Endocrinol; 1998 Apr; 139(1-2):15-24. PubMed ID: 9705070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T-box near the zinc fingers of the human vitamin D receptor is required for heterodimeric DNA binding and transactivation.
    Hsieh JC; Jurutka PW; Selznick SH; Reeder MC; Haussler CA; Whitfield GK; Haussler MR
    Biochem Biophys Res Commun; 1995 Oct; 215(1):1-7. PubMed ID: 7575575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
    Solomon C; Macoritto M; Gao XL; White JH; Kremer R
    J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site.
    Hsieh JC; Jurutka PW; Nakajima S; Galligan MA; Haussler CA; Shimizu Y; Shimizu N; Whitfield GK; Haussler MR
    J Biol Chem; 1993 Jul; 268(20):15118-26. PubMed ID: 8392065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,25-dihydroxyvitamin D3 modulates phosphorylation of serine 205 in the human vitamin D receptor: site-directed mutagenesis of this residue promotes alternative phosphorylation.
    Hilliard GM; Cook RG; Weigel NL; Pike JW
    Biochemistry; 1994 Apr; 33(14):4300-11. PubMed ID: 8155647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evidence for a 170-kilodalton, AF-2-dependent vitamin D receptor/retinoid X receptor coactivator that is highly expressed in osteoblasts.
    Jurutka PW; Remus LS; Whitfield GK; Galligan MA; Haussler CA; Haussler MR
    Biochem Biophys Res Commun; 2000 Jan; 267(3):813-9. PubMed ID: 10673374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun.
    Li LA; Chiang EF; Chen JC; Hsu NC; Chen YJ; Chung BC
    Mol Endocrinol; 1999 Sep; 13(9):1588-98. PubMed ID: 10478848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.